# Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer

> **NCT02445456** · NA · TERMINATED · sponsor: **Oxford University Hospitals NHS Trust** · enrollment: 15 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Sienna+ injection
- **OTHER:** MRI scan
- **PROCEDURE:** Surgery to excise rectal cancer
- **DEVICE:** Sentimag probe

## Key facts

- **NCT ID:** NCT02445456
- **Lead sponsor:** Oxford University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Logistical difficulties in recruiting patients led to slower than expected recruitment. Recruitment was completely suspended during Covid and will not be restarted.
- **Last updated:** 2022-07-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02445456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02445456, "Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02445456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*